5 Biotechs Awaiting FDA Decisions in January 2018 Post author:Sam Post published:December 27, 2017 Post category:BioPharma From 1997 through 2013, there was an average of 27 novel drugs approved in the U.S. per year. Source: BioSpace You Might Also Like Why Bay Area's XOMA Surged 700% in 2017 by Not Making Drugs January 25, 2018 Array Biopharma Spun Off Heart Drug R&D Into New Subsidiary Yarra Therapeutics December 26, 2017 OvaScience Pinks Slips Nearly 50% of Workforce January 3, 2018